{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:07:13Z","timestamp":1790068033060,"version":"4.0.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":2539,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Various factors play a role in the development of erectile dysfunction (ED).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To provide a descriptive comparison of erectile function response for tadalafil on-demand (PRN) and once-daily (OAD) dosing regimens in patients with common comorbid conditions, treatments, or risk factors that can be considered when treating ED.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 17 PRN and 4 OAD placebo-controlled studies were included in the integrated database in these pooled analyses. Data were analyzed from patients treated with placebo, tadalafil 10 mg (low dose), and 20 mg (high dose) for the PRN studies and placebo, tadalafil 2.5 mg (low dose), and 5 mg (high dose) for the OAD studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>The effects of tadalafil were measured using the International Index of Erectile Function administered from baseline to week 12. A descriptive comparison of the efficacy of tadalafil PRN vs OAD was examined in the clinical populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Baseline characteristics of 4,354 men were comparable between the PRN and OAD groups, with differences seen only in the variables of race, body mass index (BMI) of at least 30 kg\/m2, and alcohol use. Tadalafil was efficacious at improving erectile function for all clinical populations, except for the low-dose OAD group, which demonstrated a weaker effect vs placebo than the high-dose OAD group, and the low- and high-dose PRN groups vs placebo for patients with BMI of at least 30 kg\/m2 for patients without a cardiovascular disorder, smokers, patients with ED duration shorter than 1 year, and patients without previous phosphodiesterase type 5 inhibitor use. Tadalafil was efficacious for patients with or without diabetes mellitus, arterial hypertension, hyperlipidemia, and alcohol use at baseline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Tadalafil OAD and PRN regimens showed efficacy in patients with ED. No clinical populations of patients with ED seemed to benefit overwhelmingly from one dose regimen over the other.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.jsxm.2016.02.171","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T15:56:17Z","timestamp":1461945377000},"page":"860-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men with Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases"],"prefix":"10.1093","volume":"13","author":[{"given":"Gerald","family":"Brock","sequence":"first","affiliation":[{"name":"Western University , London, ON , Canada"},{"name":"Canadian Urological Association , London, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ni","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN , USA"},{"name":"Lilly Research Laboratories , Indianapolis, IN , USA"},{"name":"Lilly Corporate Center , Indianapolis, IN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Oelke","sequence":"additional","affiliation":[{"name":"Department of Urology , Hannover, , Germany"},{"name":"Hannover Medical School , Hannover, , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mulhall","sequence":"additional","affiliation":[{"name":"Urology Service , New York, NY , USA"},{"name":"Department of Surgery , New York, NY , USA"},{"name":"Memorial Sloan Kettering Cancer Center , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Mid Michigan Health Centers , Jackson, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Seftel","sequence":"additional","affiliation":[{"name":"Cooper Medical School of Rowan University , Camden, NJ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"D'Souza","sequence":"additional","affiliation":[{"name":"inVentiv Health Company , Indianapolis, IN , USA"},{"name":"LLC , Indianapolis, IN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Barry","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Basingstoke, Hampshire , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,1]]},"reference":[{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0090-4295(00)00614-2","article-title":"Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?","volume":"56","author":"Derby","year":"2000","journal-title":"Urology"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jsm.12794","article-title":"Effect of aging and cardiovascular risk factors on receptor tie1 expression in human erectile tissue","volume":"12","author":"Fonseca","year":"2015","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1743-6109.2012.02816.x","article-title":"Modifying risk factors to prevent and treat erectile dysfunction","volume":"10","author":"Glina","year":"2013","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/HJH.0000000000000519","article-title":"Factors modifying the effect of blood pressure on erectile function","volume":"33","author":"Korhonen","year":"2015","journal-title":"J Hypertens"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1743-6109.2004.10106.x","article-title":"Epidemiology\/risk factors of sexual dysfunction","volume":"1","author":"Lewis","year":"2004","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.12591","article-title":"How does obesity affect fertility in men\u2014and what are the treatment options?","volume":"82","author":"Stokes","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1525-1497.2006.00554.x","article-title":"Self-esteem, confidence, and relationships in men treated with sildenafil citrate for erectile dysfunction: results of two double-blind, placebo-controlled trials","volume":"21","author":"Althof","year":"2006","journal-title":"J Gen Intern Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10532528.2006.10559839","article-title":"Sexual therapy in the age of pharmacotherapy","volume":"17","author":"Althof","year":"2006","journal-title":"Annu Rev Sex Res"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006842-199807000-00011","article-title":"The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study","volume":"60","author":"Araujo","year":"1998","journal-title":"Psychosom Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1464-410X.2006.06586.x","article-title":"The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners","volume":"99","author":"Brock","year":"2007","journal-title":"BJU Int"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jsm.12374","article-title":"A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man\u2019s inability to have sex?","volume":"11","author":"McCabe","year":"2014","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ncpuro0186","article-title":"Drug insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction","volume":"2","author":"Briganti","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-151-9-200911030-00150","article-title":"Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and metaanalysis","volume":"151","author":"Tsertsvadze","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1743-6109.2004.04029.x","article-title":"Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study","volume":"1","author":"Chen","year":"2004","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.ijir.3900944","article-title":"A double-blind, randomised-placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea","volume":"15","author":"Choi","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1442-2042.2006.01393.x","article-title":"Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men","volume":"13","author":"Guo","year":"2006","journal-title":"Int J Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1745-7262.2006.00213.x","article-title":"Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study","volume":"8","author":"Yip","year":"2006","journal-title":"Asian J Androl"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-5491.2007.02338.x","article-title":"Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction","volume":"25","author":"Hatzichristou","year":"2008","journal-title":"Diabet Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1743-6109.2009.01222.x","article-title":"Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily","volume":"6","author":"Rubio-Aurioles","year":"2009","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ijir.2009.22","article-title":"Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily","volume":"21","author":"Seftel","year":"2009","journal-title":"Int J Impot Res"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1185\/03007995.2014.946125","article-title":"Decision tree analyses of key patient characteristics in Middle Eastern\/North African and Latin American men treated with long-acting and short-acting PDE5 inhibitors for erectile dysfunction","volume":"31","author":"Rubio-Aurioles","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ijir.2013.31","article-title":"Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil","volume":"26","author":"Sontag","year":"2014","journal-title":"Int J Impot Res"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jsm.12818","article-title":"Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5\u2009mg once daily","volume":"12","author":"Burns","year":"2015","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1464-410X.2004.04819.x","article-title":"The efficacy and safety of tadalafil: an update","volume":"93","author":"Carson","year":"2004","journal-title":"BJU Int"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.eururo.2004.04.026","article-title":"Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction","volume":"46","author":"Skoumal","year":"2004","journal-title":"Eur Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2164\/jandrol.111.015289","article-title":"Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function men with erectile dysfunction but na\u00efve to phosphodiesterase type 5 inhibitors","volume":"33","author":"Porst","year":"2012","journal-title":"J Androl"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.urology.2014.11.058","article-title":"Effect of tadalafil once daily on penile length loss and morning erections in patients after bilateral nerve-sparing radical prostatectomy: results from a randomized controlled trial","volume":"85","author":"Brock","year":"2015","journal-title":"Urology"},{"key":"2023041406274009100_","first-page":"1195","article-title":"Evaluation of the efficacy of once-daily use of tadalafil vs on-demand use. Is there a cumulative effect?","volume":"62","author":"Jamshidian","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1742-1241.2012.02946.x","article-title":"Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunction","volume":"66","author":"Kang","year":"2012","journal-title":"Int J Clin Pract"},{"key":"2023041406274009100_","first-page":"472","article-title":"Effects of tadalafil on erectile dysfunction: on-demand versus once-daily dosing","volume":"18","author":"Tang","year":"2012","journal-title":"Zhonghua Nan Ke Xue"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.eururo.2013.09.037","article-title":"Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies","volume":"65","author":"Porst","year":"2014","journal-title":"Eur Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1743-6109.2005.00068.x","article-title":"The efficacy of tadalafil in clinical populations","volume":"2","author":"Lewis","year":"2005","journal-title":"J Sex Med"},{"key":"2023041406274009100_","volume-title":"Clinical study results for Cialis","author":"Cialis"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1743-6109.2011.02353.x","article-title":"A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are na\u00efve to PDE5 inhibitors","volume":"8","author":"Montorsi","year":"2011","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1743-6109.2011.02506.x","article-title":"Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile","volume":"9","author":"Araujo","year":"2012","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile function","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinternmed.2011.440","article-title":"The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis","volume":"171","author":"Gupta","year":"2011","journal-title":"Arch Intern Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2605.2009.01017.x","article-title":"Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial","volume":"33","author":"Reis","year":"2010","journal-title":"Int J Androl"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/jsm.12486","article-title":"Concurrent relations among cigarette smoking status, resting heart rate variability, and erectile response","volume":"11","author":"Harte","year":"2014","journal-title":"J Sex Med"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/and.12393","article-title":"Effects of cigarette smoking on erectile dysfunction","volume":"47","author":"Kovac","year":"2015","journal-title":"Andrologia"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(91)80350-G","article-title":"Cigarette smoking and other vascular risk factors in vasculogenic impotence","volume":"38","author":"Shabsigh","year":"1991","journal-title":"Urology"},{"key":"2023041406274009100_","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.pcan.4501013","article-title":"Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men","volume":"11","author":"Namiki","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516003519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516003519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/5\/860\/49885717\/jsm_13_5_860.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/5\/860\/49885717\/jsm_13_5_860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T22:58:27Z","timestamp":1748905107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/13\/5\/860\/6940063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,1]]},"published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.02.171","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,5]]},"published":{"date-parts":[[2016,5,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.02.171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Eli Lilly and Company. Published by Elsevier Inc. on behalf of International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}